Related news for: Professor John Hooper
Ovarian cancer may be one of the lesser recognised women’s cancers, but it is one of the deadliest...
Ovarian cancer developments in the “Year of the Agent”
A new era of ovarian cancer research has begun, with Queensland studies receiving a record-breaking four out of eight grants.
Multi-grant success for ovarian cancer research
Professor John Hooper and his team based at TRI, receives accolade that will allow them to progress ovarian cancer research to clinical trial.
Accolade for ovarian cancer research achievement
February is Ovarian Cancer Awareness Month held to educate people however Mater is providing hope with research and treatment.
Ovarian Cancer Research at Mater
Prof John Hooper & his team are working towards improving the diagnosis & treatment of ovarian cancer by developing a unique PET imaging agent that shows the exact location and extent of the tumour.
Increasing the visibility of cancer
Mater Research Institute-University of Queensland (MRI-UQ) has been awarded $3.2 million in National Health and Medical Research Council (NHMRC) funding, following the annual grant announcement.
MRI-UQ research recognised with NHMRC project funding